AT&T Ord [Cdi] (T)
$30.20 0.00 (0.00%)
16:57 EDT T Stock Quote Delayed 30 Minutes
Previous Close $30.20
Market Cap 221.25B
PE Ratio 6.10
Volume (Avg. Vol.) 30.95M
Day's Range 30.10 - 30.77
52-Week Range 26.08 - 39.70
Dividend & Yield 2.00 (6.62%)
T Stock Predictions, Articles, and AT&T Ord [Cdi] News
- From InvestorPlace
- From the Web
As 5G begins to roll out, now is the time to invest in the winners. These are among the best 5G stocks bound for long-term gains.
5G stocks are bound to be even hotter soon, as the technology is getting to critical mass. These companies will lead the megatrend.
Investor sentiment has shifted to a protective stance under the context of ever-rising tensions between the U.S. and China. In this environment, investors should consider stocks to buy now from a list of stable dividend aristocrats.
AT&T (T) earnings for the wireless company's second quarter of 2020 have T stock down on Thursday after missing revenue estimates.
These five stable stocks pay big and sustainable dividends in a world where the "income" part of fixed income is disappearing.
High dividend yield stocks across sectors. These companies have robust cash flows and earnings growth visibility.
Today's market could be a great time to start investing, and beginner investors should consider these names as some of the top stocks to buy.
It might seem like the longest of long shots. However, there’s still a chance that President Trump will win his second term and that means you need to adjust your strategy for presidential stocks to buy.
The entertainment sector has been hit hard during the coronavirus pandemic, but as the coronavirus outbreak diminishes, these stocks can rebound back to full throttle.
Coronavirus accelerated the trend, but streaming stocks were already on the rise. Here are four such stocks worth keeping an eye on.
T stock may look like a solid, blue chip dividend stock at first glance. However, questionable strategic decisions may have it on the same bearish path as General Electric.
Streaming stocks are winning big amid the coronavirus pandemic, and this winning will continue long after the pandemic fades.
So, which high-yielding dividend stocks should you consider? Taking a look at large cap names, these five come to mind as solid opportunities: Altria Group (NYSE:MO) AT&T (NYSE:T) ExxonMobil (NYSE:XOM) IBM (NYSE:IBM) PPL Corporation (NYSE:PPL) With dividend yields of 5% and above, these should be on any income investor's shortlist. Also, with many of them still lower than where they traded pre-pandemic, there could be upside potential as well.
While there are plenty of bargains on the market again due to the recent pullback, T, MCD, MARK, GOOGL and FB look like the best stocks to buy now to upgrade your portfolio.
Investors need to differentiate between speculative stocks rising higher than ever and proven blue-chip stocks, and stick to the latter.
Taking a look at major names, these five stand out as stocks to buy on the dip: Alphabet (NASDAQ:GOOG,NASDAQ:GOOGL) AT&T (NYSE:T) Johnson & Johnson (NYSE:JNJ) Microsoft (NASDAQ:MSFT) Starbucks (NASDAQ:SBUX) Granted, FUD (fear, uncertainty, and doubt) remain, even as markets trend higher. But, the relative strengths of these 5 names could make them buys on a pullback. Let's dive in, and find out why.
From chipmakers to wireless networks, these 5G stocks offer potential investors a few different angles to play the upcoming 5G rollout.
AT&T (T) stock is getting a boost Wednesday following the launch of HBO Max, which is the company's new premium streaming service.
Misonix to Report Fiscal 2020 Fourth Quarter Financial Results and Host Conference Call and Webcast on September 3
From Analyst Ratings
In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Misonix (MSON – Research Report), with a price target of $18.00. The company’s shares closed last Thursday at $10.95. According to TipRanks.com, Zimmerman is a 4-star analyst with an average return of 10.3% and a 48.1% success rate. Zimmerman covers the
From The Motley Fool
Analysts Offer Insights on Healthcare Companies: Theratechnologies (NASDAQ: THTX), Misonix (NASDAQ: MSON) and Zymeworks (NYSE: ZYME)
From Analyst Ratings
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Theratechnologies (THTX – Research Report), Misonix (MSON – Research Report) and Zymeworks (ZYME – Research Report) with bullish sentiments. Theratechnologies (THTX) Canaccord Genuity analyst Edward Nash maintained a Buy rating on Theratechnologies on July 10 and set
Navellier RatingsPowered by Portfolio Grader